Quantinno Capital Management LP Glaukos Corp Transaction History

Quantinno Capital Management LP

  • $7.54 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$48.9 - $75.26 $272,470 - $419,348
-5,572 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$37.23 - $50.97 $207,445 - $284,004
5,572 New
5,572 $276,000
Q3 2019

Nov 14, 2019
SELL
$58.58 - $83.91 $160,684 - $230,165
-2,743 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$63.59 - $78.71 $174,427 - $215,901
2,743 New
2,743 $207,000

Others Institutions Holding GKOS

# of Institutions
340
Shares Held
47.1M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.73B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email